JP2024523697A5 - - Google Patents

Info

Publication number
JP2024523697A5
JP2024523697A5 JP2024500059A JP2024500059A JP2024523697A5 JP 2024523697 A5 JP2024523697 A5 JP 2024523697A5 JP 2024500059 A JP2024500059 A JP 2024500059A JP 2024500059 A JP2024500059 A JP 2024500059A JP 2024523697 A5 JP2024523697 A5 JP 2024523697A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound
groups
alkyl
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523697A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/104559 external-priority patent/WO2023280296A1/en
Publication of JP2024523697A publication Critical patent/JP2024523697A/ja
Publication of JP2024523697A5 publication Critical patent/JP2024523697A5/ja
Pending legal-status Critical Current

Links

JP2024500059A 2021-07-09 2022-07-08 フェロトーシスモジュレーター、調製物、及びそれらの使用 Pending JP2024523697A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021105449 2021-07-09
CNPCT/CN2021/105449 2021-07-09
PCT/CN2022/104559 WO2023280296A1 (en) 2021-07-09 2022-07-08 Ferroptosis modulators, preparations, and uses thereof

Publications (2)

Publication Number Publication Date
JP2024523697A JP2024523697A (ja) 2024-06-28
JP2024523697A5 true JP2024523697A5 (enExample) 2025-07-14

Family

ID=84800322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500059A Pending JP2024523697A (ja) 2021-07-09 2022-07-08 フェロトーシスモジュレーター、調製物、及びそれらの使用

Country Status (7)

Country Link
US (1) US20240327393A1 (enExample)
EP (1) EP4367111A4 (enExample)
JP (1) JP2024523697A (enExample)
CN (1) CN117999259A (enExample)
CA (1) CA3223611A1 (enExample)
IL (1) IL309675A (enExample)
WO (1) WO2023280296A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257786A1 (en) * 2024-06-13 2025-12-18 Iama Therapeutics S.R.L. Benzoimidazole derivatives as nkcc1 inhibitors
CN119707781B (zh) * 2024-12-31 2026-02-10 成都地奥九泓制药厂 一种用作铁死亡抑制剂的化合物及其制备方法和用途
CN120699016A (zh) * 2025-06-20 2025-09-26 济南大学 一种恩塞芬汀的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004528335A (ja) * 2001-04-23 2004-09-16 アストラゼネカ アクチボラグ 血管新生の治療に使用のベンゾオキサジノン誘導体
US20110172217A1 (en) * 2008-09-05 2011-07-14 Shionogi & Co., Ltd. Ring-fused morpholine derivative having pi3k-inhibiting activity
AU2011239966B2 (en) * 2010-04-16 2014-05-08 Ac Immune S.A. Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
US10016439B2 (en) * 2014-01-31 2018-07-10 Ono Pharmaceutical Co., Ltd. Fused imidazole compounds
WO2020185738A1 (en) * 2019-03-11 2020-09-17 Collaborative Medicinal Development, Llc Heteroaromatic and heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders

Similar Documents

Publication Publication Date Title
Ibrahim et al. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists
JP2005509024A5 (enExample)
RU2283835C3 (ru) Производные гетероциклических соединений и лекарственные средства
RU2518462C2 (ru) Органические соединения
JP2010519304A5 (enExample)
KR970705560A (ko) 항진균 활성을 갖는 신규한 카르복사미드(new carboxamides with antifungal activity)
RU2004127925A (ru) N3-алкилированные бензимидазольные производные в качестве ингибиторов мек
HRP20100283T1 (hr) Derivati n-'(1,5-difenil-1h-pirazol-3-il)sulfonamida s afinitetom za cb1 receptor
RU96113104A (ru) Фунгицидные циклические амиды
JP2004525951A5 (enExample)
RU2007114080A (ru) N-бензилсульфонил-замещенные аналоги анилинопиримидина
JP2004509952A5 (enExample)
JP2005505586A5 (enExample)
JP2004523490A5 (enExample)
JP2009542720A5 (enExample)
RU97107457A (ru) Производное азола
RU2014121394A (ru) Двузамещенные соединения диамино-3,4-циклобутен-3-диона-1,2, приемлемые для лечения паталогий, опосредованных хемокинами
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
AR040403A1 (es) Derivados de morfolina antagonista de ccr3
JP2005529164A5 (enExample)
HRP20161260T1 (hr) Derivati (r)-arilkilamina i farmaceutski pripravci koji ih sadrže
JP2024523576A5 (enExample)
CA2574217A1 (en) Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
JP2021534254A5 (ja) 心臓弁疾患を治療するための医薬組成物
JPH1081664A5 (enExample)